+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Oculoplastic Surgery Market (2019-2025)

  • PDF Icon

    Report

  • 65 Pages
  • January 2020
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 4987614
The Asia Pacific Oculoplastic Surgery Market is expected to witness market growth of 6.98% CAGR during the forecast period (2019-2025).

A forehead lift can benefit people of any age who have formed furrows or frown lines due to stress, muscle activity or genetic disorders, such as a low, heavy brow, or clenched lines above the nose. Nonetheless, it is most commonly done procedure for people between the ages of 40 and 60, to reduce the visible effects of aging. Sometimes, the forehead lift is done in conjunction with a facelift or eyelid lift operation. The eyelids' tone and shape tend to loosen and shrink over time. That can be resolved by an eyelid lift surgery or blepharoplasty. The doctor surgically extracts excess fat, muscle, and skin from both the upper and lower eyelids during the operation to redefine eye shape.

For many purposes, oculoplastic surgery can be done but most are linked to trauma and injury. Orbital fracture repair can be important for removing bone fragments and restore the integrity of the bones around the eyeball, disentangle ocular muscles, and ease double vision or a sunken look of the eye. Repairs to facial fractures allow the surgeon to reposition or repair broken bones. The surgeon may need to restore the nerves, and/or soft tissue, and bone transplants. This is usually done with the assistance of other facial plastic surgeons. The operation for facial reconstruction may restore facial damage caused by cancer treatment, trauma, or birth defects. To reconstruct the face, surgeons may or may use surgical implants to transplant soft tissue and bone from another area of the body to produce a balanced facial appearance. Also, this is conducted with the help of other facial plastic surgeons.

Based on Procedure, the market is segmented into Eyelid Surgery, Orbital Surgery, Face Lift, Brow Lift & Forehead Lift and Pediatric Oculoplastic surgery. Based on End Use, the market is segmented into Ambulatory surgical centers and Hospitals & clinics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH), Stanford Health Care, Tekno-Medical Optik-Chirurgie GmbH, Bolton Surgical Ltd., Blink Medical Ltd. (Katena Products, Inc.), and Sklar Corporation.

Scope of the Study

Market Segmentation:

By Procedure
  • Eyelid Surgery
  • Orbital Surgery
  • Face Lift
  • Brow Lift & Forehead Lift
  • Pediatric Oculoplastic surgery

By End Use
  • Ambulatory surgical centers
  • Hospitals & clinics

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Karl Storz SE & Co. KG
  • Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
  • Stanford Health Care
  • Tekno-Medical Optik-Chirurgie GmbH
  • Bolton Surgical Ltd.
  • Blink Medical Ltd. (Katena Products, Inc.)
  • Sklar Corporation

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Oculoplastic Surgery Market, by Procedure
1.4.2 Asia Pacific Oculoplastic Surgery Market, by End Use
1.4.3 Asia Pacific Oculoplastic Surgery Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Oculoplastic Surgery Market by Procedure
3.1 Asia Pacific Eyelid Surgery Market by Country
3.2 Asia Pacific Face Lift Market by Country
3.3 Asia Pacific Orbital Surgery Market by Country
3.4 Asia Pacific Brow Lift & Forehead Lift Market by Country
3.5 Asia Pacific Pediatric Oculoplastic surgery Market by Country
Chapter 4. Asia Pacific Oculoplastic Surgery Market by End Use
4.1 Asia Pacific Ambulatory surgical centers Market by Country
4.2 Asia Pacific Hospitals & clinics Market by Country
Chapter 5. Asia Pacific Oculoplastic Surgery Market by Country
5.1 China Oculoplastic Surgery Market
5.1.1 China Oculoplastic Surgery Market by Procedure
5.1.2 China Oculoplastic Surgery Market by End Use
5.2 Japan Oculoplastic Surgery Market
5.2.1 Japan Oculoplastic Surgery Market by Procedure
5.2.2 Japan Oculoplastic Surgery Market by End Use
5.3 India Oculoplastic Surgery Market
5.3.1 India Oculoplastic Surgery Market by Procedure
5.3.2 India Oculoplastic Surgery Market by End Use
5.4 South Korea Oculoplastic Surgery Market
5.4.1 South Korea Oculoplastic Surgery Market by Procedure
5.4.2 South Korea Oculoplastic Surgery Market by End Use
5.5 Singapore Oculoplastic Surgery Market
5.5.1 Singapore Oculoplastic Surgery Market by Procedure
5.5.2 Singapore Oculoplastic Surgery Market by End Use
5.6 Malaysia Oculoplastic Surgery Market
5.6.1 Malaysia Oculoplastic Surgery Market by Procedure
5.6.2 Malaysia Oculoplastic Surgery Market by End Use
5.7 Rest of Asia Pacific Oculoplastic Surgery Market
5.7.1 Rest of Asia Pacific Oculoplastic Surgery Market by Procedure
5.7.2 Rest of Asia Pacific Oculoplastic Surgery Market by End Use
Chapter 6. Company Profiles
6.1 Zimmer Biomet Holdings, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 B. Braun Melsungen AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Integra LifeSciences Holdings Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Karl Storz SE & Co. KG
6.4.1 Company Overview
6.5 Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expense
6.6 Stanford Health Care
6.6.1 Company Overview
6.6.2 Financial Analysis
6.7 Tekno Medical Optik-Chirurgie GmbH
6.7.1 Company Overview
6.8 Bolton Surgical Ltd.
6.8.1 Company Overview
6.9 Blink Medical Ltd. (Katena Products, Inc.)
6.9.1 Company Overview
6.1 Sklar Corporation
6.10.1 Company Overview

Companies Mentioned

  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Karl Storz SE & Co. KG
  • Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
  • Stanford Health Care
  • Tekno-Medical Optik-Chirurgie GmbH
  • Bolton Surgical Ltd.
  • Blink Medical Ltd. (Katena Products, Inc.)
  • Sklar Corporation

Methodology

Loading
LOADING...